IDXX vs MEDP
Idexx Laboratories vs Medpace — AI-powered side-by-side comparison
IDXX
Idexx Laboratories
69
Buy
VS
| Metric | IDXX | MEDP |
|---|
| AI Score |
69
|
67
|
| Price |
$586.77
|
$590.35
|
| P/E Ratio |
41.20×
|
33.97×
|
| ROE |
66.0%
|
98.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
62.4%
|
28.8%
|
| Debt / Equity |
0.60×
|
0.28×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
65.3
|
64.4
|
| Beta |
1.549
|
1.151
|
| Expected Upside |
+12.3%
|
+5.5%
|
AI Committee View
Current Innellis committee reasoning for IDXX versus MEDP.
IDXX leads by 2 points.
IDXX scores 69/100 (Buy) versus MEDP at 67/100 (Buy).
IDXX Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Stochastic RSI (90.3) confirms overbought conditions.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
MEDP Committee View
80% agreement
5 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is bollinger bandwidth of 19.8% signals elevated volatility. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 19.8% signals elevated volatility — Risk